Druggable oncogene fusions in invasive mucinous lung adenocarcinoma

T Nakaoku, K Tsuta, H Ichikawa, K Shiraishi… - Clinical cancer …, 2014 - AACR
Purpose: To identify druggable oncogenic fusions in invasive mucinous adenocarcinoma
(IMA) of the lung, a malignant type of lung adenocarcinoma in which KRAS mutations …

Druggable Oncogene Fusions in Invasive Mucinous Lung Adenocarcinoma

T Nakaoku, K Tsuta, H Ichikawa, K Shiraishi… - Clinical Cancer …, 2014 - cir.nii.ac.jp
< jats: title> Abstract</jats: title>< jats: p> Purpose: To identify druggable oncogenic fusions
in invasive mucinous adenocarcinoma (IMA) of the lung, a malignant type of lung …

[引用][C] Druggable Oncogene Fusions in Invasive Mucinous Lung Adenocarcinoma

T Nakaoku - 2016 - ci.nii.ac.jp
リポジトリの登録にあたっては, Peer review された最終版のみ可能であり, その際には下記の出版
社のウェブサイトのアドレスを記載することが求められる. 当該論文は 2014 年 6 月の出版であり …

[HTML][HTML] Druggable Oncogene Fusions in Invasive Mucinous Lung Adenocarcinoma

T Nakaoku, K Tsuta, H Ichikawa… - … cancer research: an …, 2014 - ncbi.nlm.nih.gov
Purpose: To identify druggable oncogenic fusions in invasive mucinous adenocarcinoma
(IMA) of the lung, a malignant type of lung adenocarcinoma in which KRAS mutations …

[引用][C] Druggable Oncogene Fusions in Invasive Mucinous Lung Adenocarcinoma

T NAKAOKU, K TSUTA, H NOKIHARA… - Clinical cancer …, 2014 - pascal-francis.inist.fr
Druggable Oncogene Fusions in Invasive Mucinous Lung Adenocarcinoma CNRS Inist
Pascal-Francis CNRS Pascal and Francis Bibliographic Databases Simple search Advanced …

Druggable oncogene fusions in invasive mucinous lung adenocarcinoma.

T Nakaoku, K Tsuta, H Ichikawa, K Shiraishi… - … Cancer Research: an …, 2014 - europepmc.org
Druggable oncogene fusions in invasive mucinous lung adenocarcinoma. - Abstract -
Europe PMC Sign in | Create an account https://orcid.org Europe PMC Menu About Tools …

Druggable oncogene fusions in invasive mucinous lung adenocarcinoma

T Nakaoku, K Tsuta, H Ichikawa… - … : an official journal …, 2014 - pubmed.ncbi.nlm.nih.gov
Purpose To identify druggable oncogenic fusions in invasive mucinous adenocarcinoma
(IMA) of the lung, a malignant type of lung adenocarcinoma in which KRAS mutations …

Druggable Oncogene Fusions in Invasive Mucinous Lung Adenocarcinoma

T Nakaoku - 2016 - repository.kulib.kyoto-u.ac.jp
Purpose: To identify druggable oncogenic fusions in invasive mucinous adenocarcinoma
(IMA) of the lung, a malignant type of lung adenocarcinoma in which KRAS mutations …

[PDF][PDF] Druggable Oncogene Fusions in Invasive Mucinous Lung Adenocarcinoma

T Nakaoku, K Tsuta, H Ichikawa, K Shiraishi… - Clin Cancer …, 2014 - researchgate.net
Purpose: To identify druggable oncogenic fusions in invasive mucinous adenocarcinoma
(IMA) of the lung, a malignant type of lung adenocarcinoma in which KRAS mutations …

Druggable Oncogene Fusions in Invasive Mucinous Lung Adenocarcinoma

T Nakaoku - (No Title) - cir.nii.ac.jp
リポジトリの登録にあたっては, Peer review された最終版のみ可能であり, その際には下記の出版
社のウェブサイトのアドレスを記載することが求められる. 当該論文は 2014 年 6 月の出版であり …